Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew F Teich

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Acta Neuropathologica Communications|May 24, 2024
The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer diseaseHsin-Pei Wang, Rebeca Scalco, Naomi Saito, et al.
Scientific Reports|July 23, 2021
Safety evaluation of a clinical focused ultrasound system for neuronavigation guided blood-brain barrier opening in non-human primatesAntonios N Pouliopoulos, Nancy Kwon, Greg Jensen, et al.
Nature Communications|September 28, 2021
An immune response characterizes early Alzheimer's disease pathology and subjective cognitive impairment in hydrocephalus biopsiesWenrui Huang, Anne Marie Bartosch, Harrison Xiao, et al.
Acta Neuropathologica|April 6, 2026
Alzheimer's disease risk protein SorLA regulates ER homeostasis and lipid metabolism in human microglia, with conserved effects in neuronsImdadul Haq, Jason C Ngo, Nainika Roy, et al.
Journal of Alzheimer'S Disease : JAD|October 21, 2015
Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's DiseaseMauro Fà, Hong Zhang, Agnieszka Staniszewski, et al.
Journal of Alzheimer'S Disease : JAD|January 9, 2023
TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial GroupsEmily Z Huie, Anthony Escudero, Naomi Saito, et al.
Molecular Neurodegeneration|May 1, 2016
A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's diseaseJia Luo, Sue H Lee, Lawren VandeVrede, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 13, 2021
Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community studyAdam M Brickman, Jennifer J Manly, Lawrence S Honig, et al.
JAMA Network Open|April 20, 2023
Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic EthnicityLawrence S Honig, Min Suk Kang, Annie J Lee, et al.
ACS Chemical Neuroscience|February 14, 2015
Targeting human central nervous system protein kinases: An isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse modelsSaktimayee M Roy, Valerie L Grum-Tokars, James P Schavocky, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Acta Neuropathologica Communications|May 24, 2024
The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer diseaseHsin-Pei Wang, Rebeca Scalco, Naomi Saito, et al.
Scientific Reports|July 23, 2021
Safety evaluation of a clinical focused ultrasound system for neuronavigation guided blood-brain barrier opening in non-human primatesAntonios N Pouliopoulos, Nancy Kwon, Greg Jensen, et al.
Nature Communications|September 28, 2021
An immune response characterizes early Alzheimer's disease pathology and subjective cognitive impairment in hydrocephalus biopsiesWenrui Huang, Anne Marie Bartosch, Harrison Xiao, et al.
Acta Neuropathologica|April 6, 2026
Alzheimer's disease risk protein SorLA regulates ER homeostasis and lipid metabolism in human microglia, with conserved effects in neuronsImdadul Haq, Jason C Ngo, Nainika Roy, et al.
Journal of Alzheimer'S Disease : JAD|October 21, 2015
Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's DiseaseMauro Fà, Hong Zhang, Agnieszka Staniszewski, et al.
Journal of Alzheimer'S Disease : JAD|January 9, 2023
TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial GroupsEmily Z Huie, Anthony Escudero, Naomi Saito, et al.
Molecular Neurodegeneration|May 1, 2016
A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's diseaseJia Luo, Sue H Lee, Lawren VandeVrede, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 13, 2021
Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community studyAdam M Brickman, Jennifer J Manly, Lawrence S Honig, et al.
JAMA Network Open|April 20, 2023
Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic EthnicityLawrence S Honig, Min Suk Kang, Annie J Lee, et al.
ACS Chemical Neuroscience|February 14, 2015
Targeting human central nervous system protein kinases: An isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse modelsSaktimayee M Roy, Valerie L Grum-Tokars, James P Schavocky, et al.
Pageof 9